Medindia

X

inVentiv Clinical Expands Operations to Emerging Latin American Region

Friday, March 14, 2008 General News J E 4
Advertisement
SOMERSET, N.J., March 13 inVentiv ClinicalSolutions, LLC (inVentiv Clinical), a division of inVentiv Health(Nasdaq: VTIV), announced today that they will establish operations in LatinAmerica, a growing region for drug development. The new location will bebased in Sao Paulo, Brazil, with the plan to expand operations to other LatinAmerican countries. inVentiv Clinical's Latin American operations will be ledby Ana Paula Ruenis, PhD, recently appointed as Director of ClinicalOperations, Latin America. Dr. Ruenis is responsible for oversight of projectmanagement and monitoring of all Latin American investigative sites forstudies conducted by inVentiv Clinical.

Prior to joining inVentiv Clinical, Dr. Ruenis spent more than eight yearsin clinical research, representing top US pharmaceutical clients in SouthAmerica, managing trials in various phases and therapeutic areas from protocoldesign to site and patient recruitment to final report submission. Dr. Ruenisreceived both her master's degree and PhD in Pharmacology from the StateUniversity of Campinas in Piracicaba, SP, Brazil. She also received trainingat the Biopharmaceutical Sciences Department of the University of Californiain San Francisco, CA.

"Having already established full off-shore operations in India, theexpansion of our clinical operations into Latin America is an important nextstep in our goals to become a global clinical services provider," said MikeHlinak, President and CEO of inVentiv Clinical. He added, "Dr. Ruenis has theexpertise and skill to help us build our presence in South America to continueto provide superior quality services to our clients."

About inVentiv Clinical Solutions

inVentiv Clinical Solutions is the premier provider of unique clinicaloutsourcing solutions, allowing the greatest control and flexibility throughunmatched access to high quality clinical resources. As a strategic partner,inVentiv Clinical Solutions provides clinical trial management and monitoring,data management and biostatistics solutions, medical writing, regulatoryconsulting and liaison services and patient and investigator recruitment.These services are complemented by traditional clinical staffing capabilitiesthrough our industry leading staffing divisions, MedFocus and Smith HanleyConsulting Group. For more information, visit www.inventivclinical.com.

About inVentiv Health

inVentiv Health, Inc. (Nasdaq: VTIV) is an insights-driven globalhealthcare leader that provides dynamic solutions to deliver customer andpatient success. inVentiv delivers its customized clinical, sales, marketingand communications solutions through its four core business segments: inVentivClinical, inVentiv Communications, inVentiv Commercial, and inVentiv PatientOutcomes. inVentiv Health's client roster is comprised of more than 325leading pharmaceutical, biotech, life sciences and healthcare payor companies,including all top 20 global pharmaceutical manufacturers. For moreinformation, visit www.inventivhealth.com.

This press release contains forward-looking statements within the meaningof the Private Securities Litigation Reform Act of 1995. Such forward-lookingstatements involve known and unknown risks that may cause inVentiv Health'sperformance to differ materially. Such risks include, without limitation:changes in trends in the pharmaceutical industry or in pharmaceuticaloutsourcing; our ability to compete successfully with other services in themarket; our ability to maintain large client contracts or to enter into newcontracts; uncertainties related to future incentive payments; and, ourability to operate successfully in new lines of business. Readers of thispress release are referred to documents filed from time to time by inVentivHealth Inc. with the Securities and Exchange Commission for further discussionof these and other factors.

SOURCE inVentiv Health,
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Johnson & Johnson to Participate in the 28th Annua...
S
Video: New Survey Reveals More Than Half of Adults...